Intravenous (IV) magnesium sulfate (as a single short infusion) should be used as second-line therapy for severe paediatric asthma exacerbations, and for moderate exacerbations not responsive to standard first-line therapy with inhaled/nebulized medicines (short-acting beta2 agonist (SABA) and ipratropium) and systemic corticosteroids in health care facilities.